Stay Ahead of the Curve: Exciting Developments in Meningococcal Vaccines (2022-2032)
July 5, 2023 ⚊ 1 Min read ⚊ Views 64 ⚊ BLOGGlobal meningococcal vaccines market is set to expand at a 8.6% CAGR over the forecast period, reaching US$ 3.4 Bn in 2022. As per Future Market Insights (FMI), in terms of revenue, conjugate vaccines segment dominated the market with 62.6% revenue share in 2021 Rising prevalence of meningitis, growing demand for permanent cure of meningitis and private-public partnerships to provide funding for immunization programs are some factors that are expected to create opportunities for growth in the market.
Tags: Meningococcal Vaccines